Loading the section…

IMMP: financial statements from SEC — TradeAlmanac

IMMP

Immutep Limited: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	30/06/2025	30/06/2024	30/06/2023	30/06/2022
Revenue	10M	8M	5M	7M
Selling, general and administrative	9M	9M	9M	7M
Pre-tax income	−61M	−43M	−40M	−32M
Income tax	0	0	0	34
Net income	−61M	−43M	−40M	−32M
Earnings per share	−0.04	−0.04	−0.04	−0.04
Earnings per share, diluted	−0.04	−0.04	−0.04	−0.04

Balance sheet

Metric	18/08/2026	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021
Cash and equivalents	—	67M	162M	123M	80M	61M
Receivables	—	10M	7M	8M	—	—

Cash flow

Metric	30/06/2025	30/06/2024	30/06/2023	30/06/2022
Operating cash flow	−62M	−35M	−35M	−30M
Capital expenditure	45,769	29,215	82,735	22,914
Investing cash flow	−39M	−21M	−82,735	−22,914
Financing cash flow

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator